Ceruloplasmin level in women with breast disease. Preliminary results.
The average ceruloplasmin levels of 29 patients with active breast cancer and 22 patients in remission were 824 +/- 61 mg/l and 630 +/- 18 mg/l respectively. The average ceruloplasmin level of 17 patients with benign breast diseases was 555 +/- 29 mg/l and of 18 healthy women in a control group 584 +/- 17 mg/l. Breast cancer patients not in remission had ceruloplasmin levels which were significantly increased when compared to the other 3 groups. The CA 15-3 levels and ceruloplasmin levels were positively correlated. We propose that ceruloplasmin may be used as a tumour marker in the follow-up of patients with breast cancer.
Ozyilkan
O
O
Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara, Turkey.
Baltali
E
E
Ozyilkan
E
E
Tekuzman
G
G
Kars
A
A
Firat
D
D
D000328:Adult; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood*; D002570:Ceruloplasmin / Q000032:analysis*; D005260:Female; D006801:Humans; D008875:Middle Aged
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002570:Ceruloplasmin